Navigation Links
RBC Life Sciences Announces 2009 Year End Results

IRVING, Texas, March 11 /PRNewswire-FirstCall/ -- (RBC Life Sciences: OTC Bulletin Board: RBCL) — RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, wound care and pain management products, reported today company-wide net sales of $24.9 million for the year ended December 31, 2009, compared to net sales of $30.4 million for the same period during 2008.

The company also reported a net loss of $335,000, or $0.02 per diluted share, during 2009, compared to net earnings of $1.6 million, or $0.07 per diluted share, during 2008.

"In 2009, our international licensees were hobbled by the global economy overseas, which contributed disproportionately to our decline in sales," said RBC Life Sciences President and CEO John W. Price. "We did, however, see sales in this channel begin to increase late in the year as global economic conditions also began to show signs of improvement.  A bright spot in 2009 was the growth of our North American network marketing base. Sales domestically grew more than 4% percent in 2009 compared to the previous year."

Mr. Price also said that RBC Life Sciences is now compliant with industry-wide, FDA-required Good Manufacturing Practices (GMP). "The company invested substantial resources to achieve GMP compliance during 2009 and will continue to do so annually to maintain our GMP status," said Mr. Price. GMPs ensure that companies adhere to practices that promote product safety, quality and efficacy.

About RBC Life Sciences
Through U.S. and Canadian subsidiaries, RBC Life Sciences develops, manufactures and markets high-quality nutritional supplements and personal care products under its RBC Life brand to a growing population of consumers seeking wellness and a healthy lifestyle. MPM Medical, the company's medical products subsidiary, develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the company's Web site at

The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.

                              RBC Life Sciences, Inc.
                           Summary Results of Operations
                       (in thousands, except per share data)
                                                  Years Ended December 31,
                                                 2009                  2008
                                                 ----                  ----
    Net sales                                 $24,925               $30,409
    Gross profit                               12,802                15,494
    Operating profit (loss)                      (160)                2,852
    Earnings (loss) before income taxes          (324)                2,677
    Provision for income taxes                     11                 1,061
    Net earnings (loss)                          (335)                1,616
    Earnings (loss) per share – basic          $(0.02)                $0.08
    Earnings (loss) per share – diluted         (0.02)                 0.07
    Weighted average shares
     outstanding – basic                       21,921                21,465
    Weighted average shares
     outstanding – diluted                     21,921                22,839
                             RBC Life Sciences, Inc.
                            Condensed Balance Sheets
                                 (in thousands)
                                         December 31,          December 31,
                                         ------------          ------------
                                                 2009                  2008
                                                 ----                  ----
    Cash and cash equivalents                  $3,972                $4,973
    Inventories                                 5,344                 5,707
    Other current assets                        1,914                 2,245
                                                -----                 -----
      Total current assets                     11,230                12,925
    Other assets                                7,383                 6,841
                                                -----                 -----
      Total assets                            $18,613               $19,766
                                              =======               =======
    Liabilities and shareholders' equity
    Accounts payable and accrued
     liabilities                               $2,729                $3,228
    Deferred revenue                            3,669                 4,279
    Other current liabilities                     156                   144
                                                  ---                   ---
      Total current liabilities                 6,554                 7,651
    Other liabilities                           2,840                 2,728
    Shareholders' equity                        9,219                 9,387
                                                -----                 -----
      Total liabilities and
       shareholders' equity                   $18,613               $19,766
                                              =======               =======

SOURCE RBC Life Sciences, Inc.

Back to top



SOURCE RBC Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Responds to the National Acadamy of Sciences Report that Millions of Americans Get Sick Yearly from Contaminated Water
2. Moravia Worldwide to Present Webinar on Life Sciences Translation 101
3. SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program
4. Protein Sciences Corporation Announces Profitable and Cash Flow Positive Results for 2009 and Management Realignment
5. San Diego State University and BIOCOM Institute Receive $4.95 Million Grant: The BRIDGE Project, Linking Education to Employment in San Diegos Life Sciences Industry
6. Vista LifeSciences Partners with Vangard Voice Systems to Voice-Enable Medical Data Collection
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2009 Financial Results
8. Gems Medical Sciences Created to Focus on Medical & Life Science Fluid Handling
9. AMD Global Telemedicine Inc. and Texas Tech University Health Sciences Center Bring High-Tech Health Care to Children of Texas
10. Bariatric Advantage, a Division of Catalina Lifesciences, Inc. Announces Appointment of Bret Petkus to Vice-President of North American Sales.
11. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Until now, the St. Louis ... the MOMS (Management of Myelomeningocele Study) trial. One of these exclusion criteria was a ... BMI of 18.5 to 24.9 is considered normal, 25 - 29.9 is overweight and ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... . The directory is specialized and only includes chiropractic clinics in the US. ... competent and trustworthy alternative health practitioner when back pain sets in. When people ...
(Date:11/30/2015)... Creek, Michigan (PRWEB) , ... November 30, 2015 , ... ... MI, the American Cancer Society held an annual fundraising event, a 5K walk known ... a holistic treatment center for substance abuse which is also located in Battle Creek, ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... a University of Delaware Accounting and Management of Information Systems course. Based in ... mid-market businesses. Sommer will speak at before student in the Enterprise Resource Planning ...
(Date:11/30/2015)... Baltimore, MD (PRWEB) , ... November 30, 2015 , ... ... has teamed up with Public Television’s Travel With Kids to promote ... follows the Simmons family as they explore international destinations and educate families about the ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015  The ... norm in U.S. medical imaging is on ... popular accountable care payer-provider contracts are set ... in their wake, alter provider-vendor relationships. The ... will push forward new purchasing frameworks in ...
(Date:11/30/2015)... , Nov. 30, 2015 Cumberland Pharmaceuticals (CPIX), ... present live at on December 3, 2015. ... TIME: 3:15p.m. ET LINK: ... LINK: --> ... event where investors are invited to ask the company questions ...
(Date:11/30/2015)... Nov. 30, 2015 Varian Medical Systems (NYSE: VAR ... educational partnership with Apollo Hospitals Group, the largest hospital chain in ... help train radiation technologists in the country. The MoU was signed ... Knowledge, and Ashok Kakkar , Varian,s India ... India , Varian intends to deploy its Access ...
Breaking Medicine Technology: